跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vesicare - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vesicare
Approved
STANDARD
Vesicare
Astellas Pharma Europe B.V.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5af081a36aacd181
Company
Astellas Pharma Europe B.V.
Type
Standard
Approval Details
Approval Id
5af081a36aacd181
Drug Approval Philippines Name
Vesicare
Product Name
Vesicare
Registration Number
DR-XY31760
Brand Name
Vesicare
Generic Name
Solifenacin succinate
Dosage Form
Film-coated tablet
Dosage Strength
10mg
Manufacturer
Astellas Pharma Europe B.V.
Importer
Astellas Pharma Philippines, Inc.
Distributor
ZUELLIG PHARMA CORPORATION
Company Detail Path
/organization/astellas-pharma-europe-b-v
Issuance Date
12 October 2024
Expiry Date
10 October 2029
Pharmacologic Category
Muscarinic Receptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5af081a36aacd181
Type
Standard
Back to Philippines FDA Approvals